Ticker Symbol: OCMMF
Oncimmune Holdings plc
Exchange: US OTC
Country:
GB
Currency:
USD
Asset
Type: Common Stock
Company Profile
Oncimmune Holdings Plc engages in the development, manufacture, and commercialization of personalized immunodiagnostics for the screening, detection and care of cancer. Its products include EarlyCDT-Lung and EarlyCDT-Liver. The company was founded in 2002 and is headquartered in Nottinghamshire, the United Kingdom.
Sector: Health Technology
Industry: Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: D6 Building
Website: http://www.oncimmune.com
CEO: Adam Mark Hill
Tags:
- Biotechnology
- Health Technology
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $1.62 - $1.62
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 69121949
Valuation
Market Cap: 11.2B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A